EA202192418A1 - METHODS OF TREATMENT OF AL-AMYLOIDOSIS - Google Patents

METHODS OF TREATMENT OF AL-AMYLOIDOSIS

Info

Publication number
EA202192418A1
EA202192418A1 EA202192418A EA202192418A EA202192418A1 EA 202192418 A1 EA202192418 A1 EA 202192418A1 EA 202192418 A EA202192418 A EA 202192418A EA 202192418 A EA202192418 A EA 202192418A EA 202192418 A1 EA202192418 A1 EA 202192418A1
Authority
EA
Eurasian Patent Office
Prior art keywords
amyloidosis
treatment
methods
patients
relates
Prior art date
Application number
EA202192418A
Other languages
Russian (ru)
Inventor
Джин Кинни
Вагнер Заго
Кэрол Карп
Радхика Трипуранени
Original Assignee
Протена Байосайенсиз Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Протена Байосайенсиз Лимитед filed Critical Протена Байосайенсиз Лимитед
Priority claimed from PCT/IB2020/000186 external-priority patent/WO2020178638A1/en
Publication of EA202192418A1 publication Critical patent/EA202192418A1/en

Links

Abstract

Изобретение относится к составам антител и способам, пригодным для лечения пациентов с AL-амилоидозом.The invention relates to antibody formulations and methods suitable for the treatment of patients with AL-amyloidosis.

EA202192418A 2019-12-02 2020-03-05 METHODS OF TREATMENT OF AL-AMYLOIDOSIS EA202192418A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962942722P 2019-12-02 2019-12-02
PCT/IB2020/000186 WO2020178638A1 (en) 2019-03-05 2020-03-05 Methods of treating al amyloidosis

Publications (1)

Publication Number Publication Date
EA202192418A1 true EA202192418A1 (en) 2021-12-30

Family

ID=80631184

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202192418A EA202192418A1 (en) 2019-12-02 2020-03-05 METHODS OF TREATMENT OF AL-AMYLOIDOSIS

Country Status (1)

Country Link
EA (1) EA202192418A1 (en)

Similar Documents

Publication Publication Date Title
EA202092668A1 (en) ANTIBODIES TO IL-11
PH12020552229A1 (en) Il-11ra antibodies
EA201891202A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
EA201891201A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
EA201890725A1 (en) PHARNESIDE X-RECEPTOR AGONISTS AND THEIR APPLICATION
EA201890050A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
EA201890049A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
EA201890145A1 (en) ANTIBODIES TO FACTOR XI AND METHODS OF THEIR APPLICATION
EA201990778A1 (en) ANTI-IL-33 ANTIBODIES AND THEIR APPLICATION
EA201891399A1 (en) BIPIRAZOLE DERIVATIVES, SUITABLE FOR THE TREATMENT OF AUTOIMMUNE DISEASES
EA202091130A1 (en) LYOPHILIZED PREPARATION OF MONOCLONAL ANTIBODY TO TRANSTYRETIN
EA202191175A1 (en) CYSTEINE-DESIGNED ANTIBODY-DRUG CONJUGATES CONTAINING PEPTIDE-CONTAINING LINKERS
EA202191476A1 (en) HETEROAROMATIC COMPOUNDS AS VANIN INHIBITORS
EA202190810A1 (en) METHODS AND KITS FOR OBTAINING WHOLE BLOOD WITH INACTIVATED PATHOGEN
EA201792571A1 (en) THERAPEUTIC APPLICATION OF L-4-CHLOROKINURENIN
EA202191769A1 (en) TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES
EA201790336A1 (en) ANTIBODIES TO ANGIOPOETHIN-LIKE PROTEIN 4 AND METHODS OF APPLICATION
CL2021002318A1 (en) Methods of treating amyloidosis by
EA202090266A1 (en) MPO INHIBITORS FOR MEDICAL USE
EA202091112A1 (en) SOCRYSTALS, PHARMACEUTICAL COMPOSITIONS BASED ON THEIR BASED AND METHODS OF TREATMENT FOR THEIR APPLICATION
EA202090260A1 (en) MEANS AND METHODS FOR HUMAN AAV GENOTHERAPY
EA202191403A1 (en) COMPOSITION WITH HIGH PROTEIN CONCENTRATION
EA202191758A1 (en) PEPTIDES FOR THE TREATMENT AND PREVENTION OF DIABETES AND RELATED DISEASES
EA202090944A1 (en) ANTI-CD3-ANTIBODY AND A PHARMACEUTICAL COMPOSITION FOR TREATING ONCOLOGICAL DISEASES, CONTAINING IT
EA202192418A1 (en) METHODS OF TREATMENT OF AL-AMYLOIDOSIS